West Paces Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36
| Closed | -$1.02K | – | 425 |
|
|
2025
Q1 | $1.02K | Sell |
36
-7
| -16% | -$199 | ﹤0.01% | 489 |
|
|
2024
Q4 | $1.79K | Buy |
43
+35
| +438% | +$1.46K | ﹤0.01% | 449 |
|
|
2024
Q3 | $535 | Sell |
8
-1
| -11% | -$67 | ﹤0.01% | 514 |
|
|
2024
Q2 | $1.07K | Sell |
9
-7
| -44% | -$831 | ﹤0.01% | 486 |
|
|
2024
Q1 | $1.71K | Buy |
16
+10
| +167% | +$1.07K | ﹤0.01% | 469 |
|
|
2023
Q4 | $597 | Buy |
+6
| New | +$597 | ﹤0.01% | 544 |
|
|
2023
Q3 | – | Sell |
-11
| Closed | -$1.34K | – | 553 |
|
|
2023
Q2 | $1.34K | Hold |
11
| – | – | ﹤0.01% | 473 |
|
|
2023
Q1 | $1.69K | Hold |
11
| – | – | ﹤0.01% | 476 |
|
|
2022
Q4 | $1.98K | Buy |
+11
| New | +$1.98K | ﹤0.01% | 436 |
|
|
2022
Q3 | – | Sell |
-9
| Closed | -$1.29K | – | 561 |
|
|
2022
Q2 | $1.29K | Sell |
9
-1
| -10% | -$143 | ﹤0.01% | 509 |
|
|
2022
Q1 | $1.72K | Buy |
+10
| New | +$1.72K | ﹤0.01% | 492 |
|
|
2021
Q3 | – | Sell |
-23
| Closed | -$5.41K | – | 618 |
|
|
2021
Q2 | $5.41K | Hold |
23
| – | – | ﹤0.01% | 424 |
|
|
2021
Q1 | $3.01K | Buy |
+23
| New | +$3.01K | ﹤0.01% | 404 |
|